Literature DB >> 12197691

Lessons from the Women's Health Initiative: primary prevention and gender health.

Anna Day1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12197691      PMCID： PMC117851     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Deliberate self-harm and antidepressant drugs. Investigation of a possible link.

Authors:  S Donovan; A Clayton; M Beeharry; S Jones; C Kirk; K Waters; D Gardner; J Faulding; R Madeley
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

2.  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

Authors:  C Schairer; J Lubin; R Troisi; S Sturgeon; L Brinton; R Hoover
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

3.  Pharmacotherapy for obesity -- do the benefits outweigh the risks?

Authors:  J E Manson; G A Faich
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

4.  Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.

Authors:  L A Rubin; G A Hawker; V D Peltekova; L J Fielding; R Ridout; D E Cole
Journal:  J Bone Miner Res       Date:  1999-04       Impact factor: 6.741

5.  A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

Authors:  F Grodstein; J E Manson; G A Colditz; W C Willett; F E Speizer; M J Stampfer
Journal:  Ann Intern Med       Date:  2000-12-19       Impact factor: 25.391

6.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors:  Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

7.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.